Brief: Immunovia and Erlangen University Hospital Enter Into A Collaboration Agreement

Immunovia AB (publ)

17/07/2019 07:16

July 17 (Reuters) - Immunovia AB (publ)  IMMNOV.ST :
    * ERLANGEN UNIVERSITY HOSPITAL AND IMMUNOVIA ENTER INTO A COLLABORATION AGREEMENT FOR THE
COLLECTION OF PANCREATIC CANCER BLOOD SAMPLES FOR THE FINAL STEPS OF IMMRAY™ PANCAN-D
DEVELOPMENT
    * ERLANGEN UNIVERSITY HOSPITAL BECOMES FIRST CANCER CENTER IN GERMANY TO JOIN CO'S GLOBAL
NETWORK
OF KEY OPINION LEADERS IN QUEST FOR EARLY DIAGNOSIS OF PANCREATIC CANCER
    * ERLANGEN UNIVERSITY HOSPITAL WILL, IN ADDITION TO CO'S ALREADY EXISTING COLLABORATIONS,
SUPPLY
BLOOD SAMPLES FOR FINAL TWO STEPS TO MARKET OF IMMRAY

Source text for Eikon:  ID:nWkr5wsHL5 
Further company coverage:  IMMNOV.ST 

 (Gdynia Newsroom)
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))